Hope for heart attack patients as scientists use stem cells to repair damaged organ in pigs
Scientists from Germany, Sweden and the drug company AstraZeneca were able to regenerate heart cells in pigs using human ventricular progenitor (HVPs) cells. (Source: the Mail online | Health)
Source: the Mail online | Health - May 13, 2022 Category: Consumer Health News Source Type: news

Dapagliflozin's HFpEF Win; Angiograms of the HIV+; Side Effects of PCSK9 Inhibitors?
(MedPage Today) -- For heart failure patients with mildly reduced or preserved ejection fraction in the DELIVER trial, dapagliflozin (Farxiga) helped reduce the risk of cardiovascular death and worsening heart failure, AstraZeneca announced, paving... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 10, 2022 Category: Cardiology Source Type: news

Enhertu Approved in the US for Patients with HER2-Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen
Approval broadens indication for AstraZeneca and Daiichi Sankyo’s Enhertu to earlier use in metastatic breast cancer Based on ground-breaking DESTINY-Breast03 results showing Enhertu reduced the risk of disease progression or death by 72%... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 6, 2022 Category: Drugs & Pharmacology Source Type: news

Positive Topline Results for Dapagliflozin in HFpEF: DELIVER Positive Topline Results for Dapagliflozin in HFpEF: DELIVER
AstraZeneca says regulatory submissions will be forthcoming, potentially bringing a second SGLT2 inhibitor in this space, after empagliflozin.News Alerts (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 5, 2022 Category: Internal Medicine Tags: Cardiology News Alert Source Type: news

AstraZeneca Covid booster shot effective against severe disease, UK study finds
The researchers from the UK Health Security Agency, London, estimated vaccine effectiveness by analysing data on all adults aged 18 years and above who were vaccinated with the AstraZeneca primary vaccine and either the same or the Pfizer booster vaccine. A total of 43,171 individuals received an AstraZeneca booster dose, while 13,038,908 individuals received a Pfizer booster dose. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2022 Category: Pharmaceuticals Source Type: news

Fuad El-Hibri, Who Led a Troubled Vaccine Maker, Dies at 64
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses. (Source: NYT Health)
Source: NYT Health - May 2, 2022 Category: Consumer Health News Authors: Clay Risen Tags: El-Hibri, Fuad Deaths (Obituaries) Emergent BioSolutions Inc Vaccination and Immunization Coronavirus (2019-nCoV) Anthrax Drugs (Pharmaceuticals) United States Politics and Government AstraZeneca PLC Johnson & Source Type: news

HPV jab using same tech as AstraZeneca Covid vaccine could combat cervical cancer in adults
A trial is under way at several NHS hospitals giving more than 50 women who test positive for pre-cancerous tissue on their cervix a specially designed HPV jab. (Source: the Mail online | Health)
Source: the Mail online | Health - April 30, 2022 Category: Consumer Health News Source Type: news

Fuad El-Hibri, Who Led a Troubled Vaccine Maker, Dies at 64
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses. (Source: NYT Health)
Source: NYT Health - April 30, 2022 Category: Consumer Health News Authors: Clay Risen Tags: El-Hibri, Fuad Deaths (Obituaries) Emergent BioSolutions Inc Vaccination and Immunization Coronavirus (2019-nCoV) Anthrax Drugs (Pharmaceuticals) United States Politics and Government AstraZeneca PLC Johnson & Source Type: news

Most Americans Have Had COVID-19. That Doesn ’t Mean They Won’t Get It Again
Odds are, you’ve had COVID-19—whether you know it or not. Almost 60% of people in the U.S. have antibodies in their blood that suggest they’ve been infected by SARS-CoV-2, the virus that causes COVID-19, according to new estimates from the U.S. Centers for Disease Control and Prevention. But that doesn’t mean 60% of people in the U.S. are immune to COVID-19. “We know that is not what this means. Reinfection happens,” said Dr. Kristie Clarke, co-lead for the CDC’s COVID-19 Epidemiology and Surveillance Taskforce Seroprevalence Team, during a press briefing on April 26. “Protec...
Source: TIME: Health - April 29, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

AstraZeneca to open R & D center, new Alexion HQ in Kendall Square
The European life sciences giant will move about 1,500 employees to the facility. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 29, 2022 Category: American Health Authors: Greg Ryan Source Type: news

AstraZeneca sales beat forecasts on Covid jab demand
Revenue rises 60% as Alexion acquisition and its rare diseases medicines boost drugmaker’s earnings (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 29, 2022 Category: Pharmaceuticals Source Type: news

Global expansion on the rise for life sciences companies in Montgomery County, Maryland
The global life science companies choosing to have their U.S. headquarters or a major U.S. presence here, in Montgomery County, Maryland, are stacking up. Major companies from around the world have found success, including GlaxoSmithKline, AstraZeneca. NobelPharma, Macrogen, Aurinia and Lonza. Montgomery County is the perfect landing spot for a U.S. headquarters or to build manufacturing facilities. The National Institutes of Health (NIH), the world’s largest researcher of human health, is located… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 28, 2022 Category: American Health Authors: Montgomery County Economic Development Corporation Source Type: news

Monitoring reports of the effectiveness of COVID-19 vaccination, UKHSA (updated 28th April 2022)
Data on the real-world efficacy of the COVID-19 vaccines. 28 April 2022Added ' Effectiveness of AstraZeneca COVID-19 booster vaccination against the Omicron and Delta variants ' . 25 March 2022Added link to effectiveness of the COVID-19 vaccines against the Omicron BA.2 sub-lineage study. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 28, 2022 Category: Consumer Health News Source Type: news

Professor Linda shares exactly why AstraZeneca is no longer used as booster jab
ONE OF THE UK's leading public health professors has explained why the COVID-19 vaccine by AstraZeneca is less likely to be used. (Source: Daily Express - Health)
Source: Daily Express - Health - April 23, 2022 Category: Consumer Health News Source Type: news

I Tested Positive for COVID-19. Should I Take an Antiviral or Antibody Treatment?
With the Omicron variant still circulating widely around the world, and at-home tests for COVID-19 becoming increasingly popular, more people are testing positive for SARS-CoV-2. That’s leaving them wondering if there is anything they can do to cut down the number of their sick days, and, more importantly, to ​​reduce the chance of getting severely ill. Here’s a breakdown of which treatments are available, who should use them, and when. Can anyone who tests positive for COVID-19 get a drug treatment? For now, COVID-19 therapies aren’t meant for the vast majority of people who might test positi...
Source: TIME: Health - April 20, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news